Percutaneous placement of self-expandable metallic stents in patients with obstructive jaundice due to hepatocellular carcinoma

Author: Hyun Pyo HONG ¹ ; Kyungmin PARK
Author Information

1. Department of Radiology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea. summersonrad@naver.com
Publication Type:Review
Keywords: Bile ducts; Carcinoma, hepatocellular; Jaundice; Stents
MeSH: Bile Ducts; Carcinoma, Hepatocellular; Decompression; Humans; Jaundice; Jaundice, Obstructive; Palliative Care; Stents; Thrombosis
From:Gastrointestinal Intervention 2018;7(2):85-87
CountryRepublic of Korea
Language:English
Abstract: “Icteric type hepatoma” is a hepatocellular carcinoma (HCC) with tumor invasion to the bile duct (bile duct tumor thrombus, BDTT) causing obstructive jaundice. Effective and long-term decompression of the bile duct is essential for the palliative treatment for the patients. Percutaneous self-expandable metallic stent placement is a well-established treatment for palliating patients with an inoperative malignant biliary obstruction. This article reviews the treatment of percutaneous placement of self-expandable metallic stents for the management of obstructive jaundice caused by HCC.